tirzepatide cause itching & Zepbound Rash and Injection-Site Reactions: Causes, Treatment, and Prevention Severe reaction to tirzepatide injection

Online forums, TikTok, and patient communities share detailed click-counting charts

These online platforms make it convenient for consumers looking to avoid having to go back and forth with their insurance and doctors, with a catch: They can be unregulated

Physical activity, dietary factors, and behavioral interventions could plausibly explain sustained weight loss in a subset of patients and must be incorporated into future analyses

UHCs typical prior authorization requirements for Wegovy and Zepbound include: BMI documentation A documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea Comorbidity evidence Clinical records documenting the specific comorbidities that support the medical necessity of treatment Supervised weight management history Evidence of participation in a structured weight management program, which may include diet, exercise, and behavioral counseling, typically for 3 to 6 months prior to the request Prescriber qualifications The prescriber must be a physician, nurse practitioner, or physician assistant with appropriate prescribing authority UHC reviews prior authorizations against specific clinical policy bulletins

Possible concerns for older adults include: loss of bone or muscle mass (or both) if weight loss is too rapid or not paired with resistance exercise (also called strength training) nutrient deficiencies if their appetite decreases without balancing nutrition, which can worsen existing vitamin B12, vitamin D, and protein deficiencies dehydration, dizziness, or digestive system side effects (such as diarrhea), which may cause new or worsened health problems hypoglycemia (low blood sugar) or hypotension (low blood pressure), which can affect people already taking medications for these conditions increased heart rate or increased blood pressure, which may carry a higher risk in older adults who have heart disease or take heart medications Glucagon-like peptide-1 (GLP-1) receptor agonists are prescription drugs used for weight management and other conditions